Literature DB >> 7726531

Effect of inflammation on intraocular penetration of intravenous ofloxacin in albino rabbits.

G Gatti1, G Panozzo.   

Abstract

The effect of inflammation on the intraocular penetration of ofloxacin was studied in 20 albino rabbits (New Zealand White). Inflammation was induced in the left eye by inoculation of a suspension of 10(9) CFU of heat-killed Staphyloccus epidermidis per 0.1 ml of saline solution (0.9%) in the midvitreous cavity. The other eye was kept as a control. Twenty-four hours following inoculation, ofloxacin was administered in the marginal ear vein at a dose of 15 mg/kg over 20 min with an infusion pump. Animals were sacrificed at different times up to 24 h following drug administration. Ofloxacin levels were determined in aqueous humor, vitreous humor, and serum by a bioassay. Inflammation was scored on the basis of perilimbal and corneal reactions and vitreoretinal statuses. Inflammation had a relevant effect on intraocular penetration of ofloxacin, with levels in the ocular fluids of the inflamed eye markedly exceeding the ones of the control eye. In the uninflamed eye, the levels were rapidly decaying below assay sensitivity and were no longer detectable at approximately 5 h following drug administration while they were still detectable in both ocular fluids of the inflamed eye at 24 h. Ofloxacin levels in the ocular fluids of the inflamed eye were superior to the MIC for several of the bacteria which commonly cause endophthalmitis, including Staphylococcus epidermidis, Staphylococcus aureus, most members of the family Enterobacteriaceae, Haemophilus influenzae, and strains of Pseudomonas aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7726531      PMCID: PMC162578          DOI: 10.1128/AAC.39.2.549

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  20 in total

1.  Dissecting ocular tissue for intraocular drug studies.

Authors:  R Abel; G L Boyle
Journal:  Invest Ophthalmol       Date:  1976-03

2.  The intravitreal penetration of orally administered ciprofloxacin in humans.

Authors:  G Keren; A Alhalel; E Bartov; R Kitzes-Cohen; E Rubinstein; S Segev; G Treister
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-07       Impact factor: 4.799

3.  Pars plana vitrectomy as a primary treatment for acute bacterial endophthalmitis.

Authors:  D M Eichenbaum; N S Jaffe; H M Clayman; D S Light
Journal:  Am J Ophthalmol       Date:  1978-08       Impact factor: 5.258

4.  Vitreous cefazolin levels after intravenous injection. Effects of inflammation, repeated antibiotic doses, and surgery.

Authors:  D F Martin; L A Ficker; H A Aguilar; S K Gardner; L A Wilson; T A Meredith
Journal:  Arch Ophthalmol       Date:  1990-03

5.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

6.  Safety and pharmacokinetics of multiple doses of intravenous ofloxacin in healthy volunteers.

Authors:  D R Guay; J A Opsahl; F G McMahon; R Vargas; G R Matzke; S Flor
Journal:  Antimicrob Agents Chemother       Date:  1992-02       Impact factor: 5.191

7.  The clinical spectrum of endophthalmitis: incidence, predisposing factors, and features influencing outcome.

Authors:  S K Shrader; J D Band; C B Lauter; P Murphy
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

8.  Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits.

Authors:  I Cochereau-Massin; J Bauchet; F Faurisson; J M Vallois; P Lacombe; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

9.  Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis.

Authors:  I Cochereau-Massin; J Bauchet; S Marrakchi-Benjaafar; A Saleh-Mghir; F Faurisson; J M Vallois; E Vallee; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

10.  Management of infectious endophthalmitis.

Authors:  R K Forster; R L Abbott; H Gelender
Journal:  Ophthalmology       Date:  1980-04       Impact factor: 12.079

View more
  3 in total

1.  Penetration of topical, oral, and combined administered ofloxacin into the subretinal fluid.

Authors:  O Cekiç; C Batman; U Yasar; Y Totan; N E Basci; A Bozkurt; O Zilelioglu; S O Kayaalp
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

2.  Vitreous penetration of levofloxacin in the uninflamed phakic human eye.

Authors:  E N Herbert; I A Pearce; J McGalliard; D Wong; C Groenewald
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Aqueous Humour Ofloxacin Concentration after Topical Instillation in Patients with Dry Eye Disease.

Authors:  Konstantinos Kagkelaris; Mohamed A El Mubarak; Panagiotis Plotas; Dimitris Panaretos; George D Panayiotakopoulos; Gregory B Sivolapenko; Constantinos D Georgakopoulos
Journal:  Medicina (Kaunas)       Date:  2022-08-01       Impact factor: 2.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.